IRIS
CALVISI, Diego Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.716
AS - Asia 5.167
SA - Sud America 3.312
EU - Europa 2.896
AF - Africa 205
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 15
Totale 20.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.482
BR - Brasile 3.002
SG - Singapore 2.432
CN - Cina 1.394
UA - Ucraina 962
HK - Hong Kong 514
DE - Germania 470
IT - Italia 385
SE - Svezia 292
FI - Finlandia 183
VN - Vietnam 169
GB - Regno Unito 150
TR - Turchia 102
CA - Canada 101
FR - Francia 96
AR - Argentina 91
IQ - Iraq 72
BD - Bangladesh 69
MX - Messico 66
EC - Ecuador 59
IN - India 56
RU - Federazione Russa 55
BE - Belgio 51
ZA - Sudafrica 50
MA - Marocco 49
VE - Venezuela 46
PK - Pakistan 45
UZ - Uzbekistan 44
AT - Austria 43
CZ - Repubblica Ceca 42
PL - Polonia 39
ID - Indonesia 38
ES - Italia 34
DZ - Algeria 33
JP - Giappone 33
CO - Colombia 31
PY - Paraguay 28
AU - Australia 26
AE - Emirati Arabi Uniti 20
JO - Giordania 19
NP - Nepal 19
CL - Cile 18
KE - Kenya 18
KR - Corea 18
AZ - Azerbaigian 17
RO - Romania 16
TN - Tunisia 16
IR - Iran 15
UY - Uruguay 15
NL - Olanda 14
EG - Egitto 13
LT - Lituania 13
DO - Repubblica Dominicana 12
IL - Israele 12
JM - Giamaica 11
SA - Arabia Saudita 11
EU - Europa 10
HN - Honduras 10
PA - Panama 10
PE - Perù 10
BO - Bolivia 9
CR - Costa Rica 9
GE - Georgia 9
OM - Oman 8
SN - Senegal 8
BG - Bulgaria 7
KZ - Kazakistan 6
PS - Palestinian Territory 6
RS - Serbia 6
AL - Albania 5
BH - Bahrain 5
BY - Bielorussia 5
LB - Libano 5
PT - Portogallo 5
BN - Brunei Darussalam 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NG - Nigeria 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
CI - Costa d'Avorio 3
DK - Danimarca 3
IE - Irlanda 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BW - Botswana 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
LU - Lussemburgo 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
Totale 20.318
Salva come PNG Salva come JPEG
Città #
Dallas 2.960
Chandler 1.428
Singapore 1.312
Jacksonville 526
Hong Kong 510
Princeton 377
Beijing 324
Ashburn 272
São Paulo 220
Nanjing 219
Wilmington 169
Sassari 168
Ann Arbor 162
Dearborn 148
Shanghai 133
Rio de Janeiro 113
Boardman 106
New York 96
Los Angeles 94
Belo Horizonte 83
Santa Clara 83
Nanchang 78
The Dalles 69
Columbus 61
Ho Chi Minh City 60
Brasília 55
Munich 55
Woodbridge 54
Shenyang 53
Tianjin 53
Council Bluffs 52
Brussels 50
Changsha 48
Hebei 46
Tashkent 42
Helsinki 41
Toronto 41
Campinas 40
Nuremberg 40
Porto Alegre 40
Jinan 38
Ribeirão Preto 36
Brno 35
Curitiba 35
Jiaxing 35
Warsaw 35
Hanoi 34
San Francisco 33
Norwalk 32
Buffalo 31
Izmir 31
Salvador 30
Tokyo 30
Andover 29
Baghdad 29
Falls Church 29
Guarulhos 28
Montreal 28
Mountain View 28
Goiânia 25
Guangzhou 25
Atlanta 23
Campo Grande 23
Hangzhou 23
Houston 23
Algiers 22
Brooklyn 22
Guayaquil 22
London 22
Ningbo 22
Kunming 21
Boston 20
Betim 19
Fortaleza 19
Johannesburg 19
Zhengzhou 19
Joinville 18
Lahore 18
Praia Grande 18
Quito 18
Stockholm 18
São Bernardo do Campo 18
Casablanca 17
Contagem 17
Denver 17
Mexico City 17
Seoul 17
Sorocaba 17
Amman 16
Aracaju 16
Baku 16
Frankfurt am Main 16
Juiz de Fora 16
Manaus 16
Osasco 16
Augusta 15
Caxias do Sul 15
Chennai 15
Leawood 15
Nairobi 15
Totale 11.853
Salva come PNG Salva come JPEG
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 324
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 205
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 186
Aberrant fucosylation sustains the NOTCH and EGFR/NF-kB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma 183
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 181
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice. 170
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 168
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 168
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes 161
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade 161
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosomine in the resistant BFF1 rat strain 160
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 160
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 159
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 158
Activation of Beta-Catenin During Hepatocarcinogenesis in Transgenic Mouse Models: Relationships to Phenotype and Tumor Grade 158
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 157
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 157
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumor formation in mice via AKT2/mTORC1 cascade. 155
Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital 153
An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling 152
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells 151
Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis 149
Activation of the canonical Wnt/Beta-catenin pathway confers growth advantages in c-My/E2F1 transgenic mouse model of liver cancer 148
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma 147
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 146
AKT/mTOR activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis. 145
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver 143
[11C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice. 142
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 141
Experimental models to define the genetic predisposition to liver cancer 140
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 139
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. 139
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 136
Accomplices in crime: The diabolical liaison between protein tyrosine phosphatase 1B and ras in hepatocellular carcinoma 135
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice 133
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 131
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 131
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 131
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 130
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 129
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma 128
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells 128
Hydrodynamic transfection for generation of novel mouse models for liver cancer research. 127
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models 126
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans 126
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 123
Combined treatment with MEK and mTOR inhibitors is effective in in Vitro and in Vivo models of hepatocellular carcinoma 122
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 122
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 121
Application of comparative functional genomics to identify best-fit mouse models to study human cancer 120
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 118
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 116
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 115
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC 115
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 115
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 114
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 114
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 114
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma 113
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 113
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development 113
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 112
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer 112
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 110
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 110
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 109
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 108
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 106
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 106
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma 105
Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis. 105
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 105
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 104
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations 104
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 103
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 103
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 102
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma? 102
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. 102
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide 102
A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors 101
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer 100
Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats 100
Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma. 98
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53 98
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma 98
The dark side of the moon: AKT as a tumor suppressor in the liver? 97
Non-functioning gastroenteropancreatic (GEP) tumors: a 111In-Pentetreotide SPECT/CT diagnostic study. 97
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 96
Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma 96
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 95
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis 93
Classification and survival prediction of hepatocellular carcinoma by gene expression profiling 93
Comparison of liver oncogenic potential among human RAS isoforms 93
Beta catenin or genomic instability define two categories of liver cancer in transgenic mice 92
The warburg effect 97 years after its discovery 92
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade 92
Sulfatase 1: A new Jekyll and Hyde in hepatocellular carcinoma? 92
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 91
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men. 91
Totale 12.680
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021900 0 0 0 0 0 101 189 8 225 215 134 28
2021/20221.077 125 9 6 10 23 36 53 65 110 55 122 463
2022/20232.421 255 222 143 409 195 384 3 248 376 10 94 82
2023/2024557 116 37 16 25 103 25 3 57 0 12 48 115
2024/20256.457 43 52 366 170 314 223 546 1.131 2.275 868 295 174
2025/20266.232 426 2.069 1.569 1.111 922 135 0 0 0 0 0 0
Totale 20.581